What's the timeline for lurbinectedin's peak effects?

Short answer:
- Peak drug levels (pharmacokinetic peak, Cmax) occur at the end of the 1-hour IV infusion.
- The strongest anti-tumor effects (clinical responses) are not immediate. They typically become evident over days to weeks, with measurable tumor responses usually assessed after several weeks of treatment.

More detail:
- IV infusion: Lurbinectedin is given as an IV infusion over about 1 hour. The plasma concentration peaks right at the end of the infusion.
- Early pharmacology: The drug binds DNA and disrupts transcription quickly, but the resulting tumor cell death accumulates over time.
- Clinical response timing: In relapsed small cell lung cancer (the approved setting), radiographic responses are typically evaluated after about 4–6 weeks (after one cycle), with many patients needing 2–3 cycles (roughly 6–12 weeks) to reach a best response. Some patients may respond earlier, others later or not at all.
- Individual variation: The exact timing depends on the tumor, prior therapy, overall health, dose modifications, and tolerability.

If you’re asking for a plan to monitor a specific patient, or want dosing/timing in more concrete terms, I can tailor the info or point you to the exact dosing schedule and monitoring guidelines.